The use of febuxostat in comorbid patients with gout in real clinical practice: own data
Objective: to evaluate the efficacy and safety of febuxostat (Azuriks®) in the treatment of patients with gout and concomitant diseases.Patients and methods. An observational, open-label, single-centre study of the results of febuxostat use in 85 gout patients with insufficient prior allopurinol eff...
Saved in:
| Main Authors: | E. V. Zonova, D. N. Orlov, A. S. Kabargina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2022-06-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1301 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The place of febuxostat in the treatment of gout
by: A. M. Novikova, et al.
Published: (2020-09-01) -
Febuxostat in patients with hyperuricemia and gout: is the nephroprotective effect real?
by: M. S. Eliseev, et al.
Published: (2024-10-01) -
Febuxostat in the therapy of gout: from theory to practice
by: E. V. Ilyinykh, et al.
Published: (2018-01-01) -
An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with renal dysfunction
by: Ryutaro Iwama, et al.
Published: (2024-12-01) -
The Experience of Using a Combination of Febuxostat and Canakinumab in Tophaceous Gout Complicated by Chronic Kidney Disease in a Teenage Patient: A Case Study
by: Maria I. Kaleda, et al.
Published: (2018-12-01)